Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > EY sees bolt-ons in the single to double digit billions now

<< Previous

Bullboard Posts

Next >>

Comment by Hcallahan44on Oct 13, 2022 10:38pm

177 Views

Post# 35023997

RE:RE:RE:RE:RE:RE:RE:RE:RE:EY sees bolt-ons in the single to double digit billions now

Thanks Westcoast....i have loaded on two other biotechs....do you follow MTNB or SAVA....some great stuff on griproom regarding MTNB....it might be the Apple of drug delivery....i think one of those will pay off a lot faster than oncy.....i think oncy is dead money for another year or two....if it bumps back to my basis i might cash out and load more sava....5 years of empty promises is enough

<< Previous

Bullboard Posts

Next >>

QNB Metals stock adds 900 per cent after white hydrogen deal